(AKZA) Akzo Nobel - Ratings and Ratios
Decorative Paints, Performance Coatings, Automotive Coatings, Powder Coatings, Protective Coatings
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.3% |
| Value at Risk 5%th | 39.4% |
| Relative Tail Risk | -5.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -4.72 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.470 |
| Beta | 0.217 |
| Beta Downside | 0.170 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.78% |
| Mean DD | 15.36% |
| Median DD | 17.35% |
Description: AKZA Akzo Nobel October 30, 2025
Akzo Nobel N.V. (ticker AKZA) is a global paints-and-coatings producer that operates through two core segments: Decorative Paints, which serve the building-renovation market, and Performance Coatings, which protect and enhance assets in automotive, marine, aerospace, oil-&-gas and other industrial applications.
The company’s portfolio spans more than 60 brands-including Dulux, Sikkens, International, and Armada-covering decorative paints, lacquers, varnishes, mixing equipment, and a full suite of specialty and powder coatings for both consumer and industrial end-users.
Its customer base is diversified across energy, packaging, infrastructure, shipbuilding, and general-industry segments such as agricultural and construction equipment, steel fabrication, pipelines, appliances and transportation.
Founded in 1646 and headquartered in Amsterdam, Akzo Nobel rebranded from Akzo NV in 1994 and is classified under GICS “Specialty Chemicals.”
Recent metrics show FY 2023 revenue of roughly €10 billion with an adjusted EBITDA margin near 13 %, while the decorative-paints segment is sensitive to housing-starts and renovation spending, and performance-coatings growth is tied to automotive electrification, marine decarbonisation, and stricter environmental regulations on coating chemicals.
For a deeper, data-driven valuation of AKZA’s upside versus its sector peers, the ValueRay platform provides a transparent, metric-level breakdown worth checking out.
AKZA Stock Overview
| Market Cap in USD | 11,724m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception | |
| Return 12m vs S&P 500 | -10.7% |
| Analyst Rating | - |
AKZA Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 3.68% |
| Yield on Cost 5y | 2.59% |
| Yield CAGR 5y | 0.77% |
| Payout Consistency | 90.6% |
| Payout Ratio | 1.8% |
AKZA Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -2.46% |
| CAGR/Max DD Calmar Ratio | -0.07 |
| CAGR/Mean DD Pain Ratio | -0.16 |
| Current Volume | 554.7k |
| Average Volume | 317.7k |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (415.0m TTM) > 0 and > 6% of Revenue (6% = 631.6m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -1.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.10% (prev 5.16%; Δ 5.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 814.0m > Net Income 415.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.77b) to EBITDA (1.17b) ratio: 3.23 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (171.0m) change vs 12m ago 0.12% (target <= -2.0% for YES) |
| Gross Margin 39.85% (prev 40.90%; Δ -1.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 73.47% (prev 73.83%; Δ -0.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.42 (EBITDA TTM 1.17b / Interest Expense TTM 179.0m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 50.55
| 1. Piotroski 2.50pt |
| 2. FCF Yield 3.52% |
| 3. FCF Margin 4.56% |
| 4. Debt/Equity 1.22 |
| 5. Debt/Ebitda 3.23 |
| 6. ROIC - WACC (= 3.28)% |
| 7. RoE 9.25% |
| 8. Rev. Trend -39.59% |
| 9. EPS Trend -29.99% |
What is the price of AKZA shares?
Over the past week, the price has changed by -6.82%, over one month by -11.29%, over three months by -4.85% and over the past year by +0.30%.
Is AKZA a buy, sell or hold?
What are the forecasts/targets for the AKZA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.7 | 27.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 55.1 | 2.2% |
AKZA Fundamental Data Overview November 18, 2025
Market Cap EUR = 10.12b (10.12b EUR * 1.0 EUR.EUR)
P/E Trailing = 175.1515
P/E Forward = 13.4771
P/S = 0.9725
P/B = 2.5149
P/EG = 1.0865
Beta = 1.141
Revenue TTM = 10.53b EUR
EBIT TTM = 792.0m EUR
EBITDA TTM = 1.17b EUR
Long Term Debt = 3.47b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.61b EUR (from shortLongTermDebt, last fiscal year)
Debt = 5.08b EUR (Calculated: Short Term 1.61b + Long Term 3.47b)
Net Debt = 3.77b EUR (from netDebt column, last fiscal year)
Enterprise Value = 13.64b EUR (10.12b + Debt 5.08b - CCE 1.55b)
Interest Coverage Ratio = 4.42 (Ebit TTM 792.0m / Interest Expense TTM 179.0m)
FCF Yield = 3.52% (FCF TTM 480.0m / Enterprise Value 13.64b)
FCF Margin = 4.56% (FCF TTM 480.0m / Revenue TTM 10.53b)
Net Margin = 3.94% (Net Income TTM 415.0m / Revenue TTM 10.53b)
Gross Margin = 39.85% ((Revenue TTM 10.53b - Cost of Revenue TTM 6.33b) / Revenue TTM)
Gross Margin QoQ = 39.53% (prev 40.11%)
Tobins Q-Ratio = 0.96 (Enterprise Value 13.64b / Total Assets 14.17b)
Interest Expense / Debt = 1.34% (Interest Expense 68.0m / Debt 5.08b)
Taxrate = 24.58% (44.0m / 179.0m)
NOPAT = 597.3m (EBIT 792.0m * (1 - 24.58%))
Current Ratio = 1.23 (Total Current Assets 6.33b / Total Current Liabilities 5.16b)
Debt / Equity = 1.22 (Debt 5.08b / totalStockholderEquity, last quarter 4.17b)
Debt / EBITDA = 3.23 (Net Debt 3.77b / EBITDA 1.17b)
Debt / FCF = 7.86 (Net Debt 3.77b / FCF TTM 480.0m)
Total Stockholder Equity = 4.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.93% (Net Income 415.0m / Total Assets 14.17b)
RoE = 9.25% (Net Income TTM 415.0m / Total Stockholder Equity 4.49b)
RoCE = 9.95% (EBIT 792.0m / Capital Employed (Equity 4.49b + L.T.Debt 3.47b))
RoIC = 8.16% (NOPAT 597.3m / Invested Capital 7.32b)
WACC = 4.88% (E(10.12b)/V(15.19b) * Re(6.82%) + D(5.08b)/V(15.19b) * Rd(1.34%) * (1-Tc(0.25)))
Discount Rate = 6.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -81.65 | Cagr: -0.26%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈557.6m ; Y1≈366.1m ; Y5≈167.4m
Fair Price DCF = 19.24 (DCF Value 3.29b / Shares Outstanding 171.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -29.99 | EPS CAGR: -62.46% | SUE: -4.0 | # QB: 0
Revenue Correlation: -39.59 | Revenue CAGR: -3.08% | SUE: -0.97 | # QB: 0